Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face

Human Pathology

Volumn 41, Issue 3, 2010, Pages 407-414

  Tokuyama, Wataru ^a   Mikami, Tetuo ^a   Masuzawa, Mikio ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cutaneous angiosarcoma; VEGF; VEGF C; VEGFR 2; VEGFR 3

Indexed keywords

ANTIBODY; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; KI 67 ANTIGEN; P21 ACTIVATED KINASE; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOSARCOMA; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CAPILLARY HEMANGIOMA; CAVERNOUS HEMANGIOMA; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FACE; GENETIC TRAIT; HUMAN; LABELING INDEX; MORPHOLOGICAL TRAIT; PARACRINE SIGNALING; PROTEIN EXPRESSION; SCALP; SIGNAL TRANSDUCTION;

AGED; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL CYCLE; CELL PROLIFERATION; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FACE; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PARACRINE COMMUNICATION; SCALP; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 75949088026     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.08.021     Document Type: Article

References (35)

1. Mark R.J., Poen J.C., Tran L.M., Fu Y.S., and Juillard G.F. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77 (1996) 2400-2406
2. Mendenhall W.M., Mendenhall C.M., Werning J.W., Reith J.D., and Mendenhall N.P. Cutaneous angiosarcoma. Am J Clin Oncol 29 (2006) 524-528
3. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7 (2006) 359-371
4. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research 312 (2006) 549-560
5. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
6. Connolly D.T., Heuvelman D.M., Nelson R., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84 (1989) 1470-1478
7. Aaronson S.A. Growth factors and cancer. Science 254 (1991) 1146-1153
8. Mokry J., Cizkova D., Filip S., et al. Nestin expression by newly formed human blood vessels. Stem Cells Dev 13 (2004) 658-664
9. Kuzu I., Bicknell R., Harris A.L., Jones M., Gatter K.C., and Mason D.Y. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 45 (1992) 143-148
10. Meis-Kindblom J.M., and Kindblom L.G. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 22 (1998) 683-697
11. Poblet E., Gonzalez-Palacios F., and Jimenez F.J. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428 (1996) 217-221
12. Suster S., and Wong T.Y. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol 16 (1994) 355-363
13. Ehrmann J., Kolar Z., and Mokry J. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 58 (2005) 222-223
14. Breiteneder-Geleff S., Soleiman A., Kowalski H., et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154 (1999) 385-394
15. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 46 (2005) 396-402
16. Kahn H.J., Bailey D., and Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15 (2002) 434-440
17. Partanen T.A., Alitalo K., and Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86 (1999) 2406-2412
18. Folpe A.L., Veikkola T., Valtola R., and Weiss S.W. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 13 (2000) 180-185
19. Itakura E., Yamamoto H., Oda Y., and Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 97 (2008) 74-81
20. Kitagawa M., Tanaka I., Takemura T., Matsubara O., and Kasuga T. Angiosarcoma of the scalp: report of two cases with fatal pulmonary complications and a review of Japanese autopsy registry data. Virchows Arch A Pathol Anat Histopathol 412 (1987) 83-87
21. Morgan M.B., Swann M., Somach S., Eng W., and Smoller B. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol 50 (2004) 867-874
22. Shin S.J., Lesser M., and Rosen P.P. Hemangiomas and angiosarcomas of the breast: diagnostic utility of cell cycle markers with emphasis on Ki-67. Arch Pathol Lab Med 131 (2007) 538-544
23. Donnell R.M., Rosen P.P., Lieberman P.H., et al. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 5 (1981) 629-642
24. Lin N., Uchi H., Moroi Y., et al. Significance of the expression of phosphorylated signal transducer and activator of transcription-3, -Akt, and -cyclin D1 in angiosarcoma. J Dermatol Sci 48 (2007) 64-66
25. Tannapfel A., Weihrauch M., Benicke M., et al. p16INK4A-alterations in primary angiosarcoma of the liver. J Hepatol 35 (2001) 62-67
26. Kaipainen A., Korhonen J., Mustonen T., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92 (1995) 3566-3570
27. Tammela T., Zarkada G., Wallgard E., et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454 (2008) 656-660
28. Cao Y., Linden P., Farnebo J., et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95 (1998) 14389-14394
29. Brown L.F., Tognazzi K., Dvorak H.F., and Harrist T.J. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 148 (1996) 1065-1074
30. Hashimoto M., Ohsawa M., Ohnishi A., et al. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 73 (1995) 859-863
31. Amo Y., Masuzawa M., Hamada Y., et al. Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation. Br J Dermatol 143 (2000) 1118-1119
32. Amo Y., Masuzawa M., Hamada Y., and Katsuoka K. Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients. Br J Dermatol 150 (2004) 160-161
33. Veikkola T., Jussila L., Makinen T., et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20 (2001) 1223-1231
34. Makinen T., Veikkola T., Mustjoki S., et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20 (2001) 4762-4773
35. Arbiser J.L., Larsson H., Claesson-Welsh L., et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol 156 (2000) 1469-1476